Questions and Answers

Yes. TMR® acts on both nociceptive pain and neuropathic pain. Evidence can be found in the literature and particularly in the scientific article by Prof. Piaggesi, entitled “Safety and effectiveness of therapeutic magnetic resonance in the management of postsurgical lesion of the diabetic foot”

(http://www.ncbi.nlm.nih.gov/pubmed/25724594) where efficacy in reducing pain during the period of TMR® treatment and for several months following the end of therapy is demonstrated.

Therapy is administered in sessions lasting about 30 minutes, 1 to 4 times a day, for a period ranging from 4 to 8 weeks, depending on the severity and type of pathology. It is possible to prolong the therapy for a longer-lasting effect especially with regard to pain and orthopedic pathologies.

The DIAPASON® is a medical device designed for home use. The patient can rent it on a monthly basis, or purchase it, by contacting our office, which will provide all the information necessary to conduct the practice. The product is delivered directly to the patient’s home by one of our trusted couriers, and included in the rental cost is the THERESON Customer Support Service, which will follow up with the patient for any needs.

Durante l’utilizzo di DIAPASON®, è possibile l’insorgere di fenomeni locali come arrossamenti o lievi formicolii. Queste manifestazioni sono indice di un corretto funzionamento del dispositivo e sono dovute al naturale processo di risposta riparatoria dei tessuti biologici.

Two clinical trials were completed, a multicenter one involving Cisanello University Hospital in Pisa, Cà Foncello Hospital in Treviso, and Pederzoli Nursing Home in Peschiera del Garda, and a single-center one at Cisanello University Hospital in Pisa on two groups of patients with post-surgical diabetic foot injuries.

No is different. Although both methods rely on electromagnetic fields, TMR® uses a stimulation signal with varying frequencies, in the 0-250 Hz range, optimized to induce cellular responses specific to ulcer healing. The signal consists of a sequence of triangular-shaped pulses of non-constant amplitudes that promote cell replication mechanisms and reduction of oxidative stress (evidence obtained in vitro and published in June 2015 in the international specialist journal “Journal of Tissue Engineering and Regenerative Medicine”).

DIAPASON® is a patented device (#0001406269) entitled “Apparatus for therapeutic treatment with pulsed electromagnetic waves resonating.” An additional patent was also filed (#TO2014A000505) entitled: “System for therapeutic treatments with electromagnetic waves,” for which we received a favorable search report that allowed us to proceed with the extension of the application at the European level.

Yes, in some cases a reduction in pain is felt only from the second week of treatment.

Pursuant to the Ministry of Health Circular dated 28/03/2013, THERESON S.p.A. warns the user that the content on the site (text, images, photos, etc.) is aimed exclusively at health professionals and has an exclusively informative content. Therefore, such information does not qualify as advertising.
THERESON S.p.A. disclaims any responsibility for consultations by non-professionals.

Request information

Our technicians, salesmen and doctors are at your disposal for any clarification on this matter. Please fill out the form or contact us directly.


Fill in the required info: